Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
Bulten W, Kartasalo K, Chen PC, Ström P, Pinckaers H, Nagpal K, Cai Y, Steiner DF, van Boven H, Vink R, Hulsbergen-van de Kaa C, van der Laak J, Amin MB, Evans AJ, van der Kwast T, Allan R, Humphrey PA, Grönberg H, Samaratunga H, Delahunt B, Tsuzuki T, Häkkinen T, Egevad L, Demkin M, Dane S, Tan F, Valkonen M, Corrado GS, Peng L, Mermel CH, Ruusuvuori P, Litjens G, Eklund M; PANDA challenge consortium. Bulten W, et al. Among authors: cai y. Nat Med. 2022 Jan;28(1):154-163. doi: 10.1038/s41591-021-01620-2. Epub 2022 Jan 13. Nat Med. 2022. PMID: 35027755 Free PMC article.
Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.
Wulczyn E, Nagpal K, Symonds M, Moran M, Plass M, Reihs R, Nader F, Tan F, Cai Y, Brown T, Flament-Auvigne I, Amin MB, Stumpe MC, Müller H, Regitnig P, Holzinger A, Corrado GS, Peng LH, Chen PC, Steiner DF, Zatloukal K, Liu Y, Mermel CH. Wulczyn E, et al. Among authors: cai y. Commun Med (Lond). 2021 Jun 30;1:10. doi: 10.1038/s43856-021-00005-3. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602201 Free PMC article.
Deep learning models for histologic grading of breast cancer and association with disease prognosis.
Jaroensri R, Wulczyn E, Hegde N, Brown T, Flament-Auvigne I, Tan F, Cai Y, Nagpal K, Rakha EA, Dabbs DJ, Olson N, Wren JH, Thompson EE, Seetao E, Robinson C, Miao M, Beckers F, Corrado GS, Peng LH, Mermel CH, Liu Y, Steiner DF, Chen PC. Jaroensri R, et al. Among authors: cai y. NPJ Breast Cancer. 2022 Oct 4;8(1):113. doi: 10.1038/s41523-022-00478-y. NPJ Breast Cancer. 2022. PMID: 36192400 Free PMC article.
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial.
Wu X, Liu J, Wang J, Wang L, Lin Z, Wang X, Zhu J, Kong B, Fei J, Tang Y, Xia B, Liang Z, Wang K, Huang Y, Zheng H, Lin A, Jiang K, Wang W, Wang X, Lou G, Pan H, Yao S, Li G, Hao M, Cai Y, Chen X, Yang Z, Chen Y, Wen H, Qu P, Xu C, Hsieh CY; FLAMES Investigators. Wu X, et al. Among authors: cai y. Nat Med. 2024 May 15. doi: 10.1038/s41591-024-03003-9. Online ahead of print. Nat Med. 2024. PMID: 38750351
15,153 results
You have reached the last available page of results. Please see the User Guide for more information.